Super-Enhancer-Associated Long Non-Coding RNA LINC01485 Promotes Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells by Regulating MiR-619-5p/RUNX2 Axis

Gu, Wenli; Jiang, Xiao; Wang, Wei; Mujagond, Prabhakar; Liu, Jingpeng; Mai, Zhaoyi; Tang, Hai; li, Simin; Xiao, Hui; Zhao, Jianjiang

doi:10.3389/fendo.2022.846154

Cited by 2 publications

(1 citation statement)

References 75 publications

(83 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Gu et al showed that LINC01485 could act as a ceRNA for miR-619-5p to affect RUNX2 expression and thus promote osteogenic differentiation of human bone marrow mesenchymal stem cells (hBMSCs). The LINC01485/miR-619-5p/RUNX2 axis may be a new target in the field of bone tissue engineering (Gu et al, 2022). Ma et al also found that CIRC-FAT1 gene downregulation suppressed colorectal carcinogenesis by sponging miR-619-5p to inhibit FOSL2 expression, providing a potential pathway for colorectal cancer treatment (Ma et al, 2022).…”

Section: Discussionmentioning

confidence: 99%

Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma

Feng

et al. 2023

Front. Genet.

View full text Add to dashboard Cite

Introduction: Lung cancer has long been at the forefront of all cancers in terms of incidence and mortality. Lung adenocarcinoma is the most common type of lung cancer, accounting for 40% of all lung cancer types. Exosomes can act as biomarkers of tumors and thus play an important role.Methods: In this article, high-throughput sequencing of miRNAs in plasma exosomes from lung adenocarcinoma patients and healthy individuals was performed to obtain 87 upregulated miRNAs, which were then combined with data from the GSE137140 database uploaded by others for screening. The database included 1566 preoperative lung cancer patients, 180 postoperative patients, and 1774 non-cancerous controls. We overlapped the miRNAs upregulated in the serum of lung cancer patients in the database relative to those of non-cancer controls and post-operative patients with the upregulated miRNAs obtained from our next-generation sequencing to obtain nine miRNAs. Two miRNAs that were not reported as tumor markers in lung cancer, hsa-miR-4454 and hsa-miR-619-5p, were selected from them and then validated by qRT-PCR, and further analysis of miRNAs was performed using bioinformatics.Results: Real-time quantitative PCR showed that the expression levels of hsa-miR-4454 and hsa-miR-619-5p in plasma exosomes of patients with lung adenocarcinoma were significantly up-regulated. The AUC values of hsa-miR-619-5p and hsa-miR-4454 were 0.906 and 0.975, respectively, both greater than 0.5, showing good performance. The target genes of miRNAs were screened by bioinformatics methods, and the regulatory network between miRNAs and lncRNAs and mRNAs was studied.Discussion: Our work demonstrated that hsa-miR-4454 and hsa-miR-619-5p have the potential to be used as biomarkers for the early diagnosis of lung adenocarcinoma.

show abstract

Section: Discussionmentioning

confidence: 99%